Raremark gets £3m to enable precision medicine in rare disease

Oct 24, 2018 · uktech.news

Screen shot 2018 10 23 at 14.42.08 898x505

HealthTech company Raremark has raised £3m from investors. The round was led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.

Julie Walters, CEO and founder of Raremark, commented on the news: "Healthcare is becoming increasingly personalized, and precision medicine is enabling the right treatments to be delivered to the right patients. However, accessing credible and structured, real-w0rld patient data remains one of the most acute challenges facing drug development in rare disease."

Lennart Hergel, partner at Ananda Ventures, explained Raremark’s approach: "Raremark has built a technology platform using content algorithms to boost engagement and advanced data analytics to understand the mechanisms, symptoms and heterogeneity of rare diseases. The resulting high-quality insights will enable companies to develop more effective treatments that are tailored to patients’ profiles."

Read Complete Article

RT @iLondoncalling: London is a RetailTech leader and @metail are a great success story https://t.co/uSefIBuXkj

RT @LDN_gov: Planning to see the fireworks this NYE? Be the first to find out when tickets are back on sale. Don’t miss out, sign up for a…

#TechX365: If the UK tech industry is so good at getting a #tech business to $1 billion, what's stopping it from gr… https://t.co/QmXv7kVeO2

Telstra connects device to 5G with Ericsson and Qualcomm https://t.co/t2K3LAW7gH by @thelaughingsub

Russian hackers are trying out this new malware against US and European targets https://t.co/0U6vVsNWff @dannyjpalmer